Dr Ng Cheng Teng was awarded the Chua Toh Hua Memorial Gold Medal for Academic Year 2014/2015. This is a university level award given to the Doctor of Philosophy graduate with the most outstanding research work done in Life Sciences.

Dr Ng Cheng Teng graduated with a PhD in June 2015 from the NUS Yong Loo Lin School of Medicine, under the main supervision of Professor Bay Boon Huat from the Department of Anatomy. Her thesis was on the “Biological Effects of Gold Nanoparticles in the Lung.” She showed exceptional promise and accomplishment at an early stage of her PhD candidature and was awarded the President Graduate Fellowship in 2013.

Her PhD work has demonstrated that the presence of gold nanoparticles ( AuNPs) is likely to induce undesirable biological effects in the lung through the generation of oxidative stress, culminating in cellular damage and inflammation. The results from this nanotoxicological study has provided data that will help to address the health concerns associated with AuNPs, which will lead to the safer use of AuNPs for biomedical applications and the industry.

Advances in nanotechnology have given rise to the rapid development of many novel applications in the biomedical field. Therefore, this raises the need to elucidate the safety and health risks of these nanomaterials. The hypothesis for her study was that gold nanoparticles (AuNPs) exert both cytotoxic and genotoxic effects in lung cells in vitro and in vivo. Initial efforts made to validate the internalization of AuNPs in human lung cells by various microscopic methods, which showed that AuNPs were taken up by clathrin-mediated endocytosis. Subsequently, she demonstrated that AuNPs were able to generate oxidative stress, concomitant with an increase in the expression of anti-oxidant genes. AuNP treatment also induced cytotoxicity of small airway epithelial cells (SAECs). Moreover, the Comet assay revealed the presence of DNA fragmentation after AuNP exposure in SAECs, concurrent with up-regulation of the DNA repair Xeroderma pigmentosum gene.

Next, a genome wide microarray study revealed altered gene expression which included serum amyloid A-1 (SAA1), toll-like receptor 2 (TLR2), miR-155 and protein S alpha 1 (PROS1). Co-immunoprecipitation assay and in silico modeling were performed with TLR2-SAA1 in SAECs andpositive results observed, confirming TLR2-SAA1 protein-protein interaction. There was also concomitant activation of NFkB activity, suggesting that SAA1-TLR2 interaction could activate NFkB.

From the epigenetic studies, the findings suggested that miR-155 and histone deacetylases activity could regulate the expression of PROS1, but not DNA methylation in AuNP-treated MRC5 lung fibroblasts. Up-regulation of miR-155 was confirmed by the luciferase assay in AuNP-treated cells, and silencing miR-155 established the PROS1 gene as a putative target gene. Nuclear chromatin condensation and re-organization were also observed at the ultrastructural level in the treated cells.

A co-culture system coupled with whole proteome analysis, using the stable isotope labeling by amino acids in cell culture (SILAC) -mass spectrometry based approach, revealed a significant perturbation of cell motility and extracellular network in the underlying lung fibroblasts, demonstrating that AuNP treatment could induce by-stander effects in neighbouring unexposed fibroblasts.

Finally, a proof of concept study was performed in male Wistar-Kyoto rats injected with AuNPs intravenously. The biodistribution analysis confirmed the accumulation of AuNPs in the rat lungs. Systemic inflammation was observed as evidenced by the increase in serum transforming growth factor beta, interleukin 6 (IL-6) and IL-1α. Prolonged blood coagulation time was observed in the AuNP-treated rats, implying that AuNP exposure could potentially lead to bleeding diathesis. Moreover, there was also inflammation of lung tissues in AuNP-treated rats, as evidenced by the presence of lymphocytic infiltration, influx of macrophages and increased IL-1α expression in the tissues. A miRNA expression profiling study showed that expression of miR-327 was significantly decreased in the single dose AuNP injection.

She has co-authored a total of nine papers in reputable journals during her candidature, including two first author papers in the high impact journal “Biomaterials”. She was also selected to represent the NUS Yong Loo Lin School of Medicine for the 6th HOPE Meeting, held in Japan in March 2014, which was organized by the Japan Society for the Promotion of Science for “excellent doctoral students and young researchers selected from countries/areas in the region to engage in inter-disciplinary discussions with Nobel laureates and other distinguished scientists”.

Top

Dr Lee Chun Fan

Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

Dr Lee Chun Fan is an assistant professor at the Centre for Quantitative Medicine at the Duke-NUS Medical School. Prior to this, he was also affiliated with the Division of Epidemiology and Biostatistics in the School of Public Health at The University of Hong Kong and the Singapore Clinical Research Institute.
His research interests comprise health-related quality-of-life studies, clinical trials, and modelling transmission of infectious disease. He has also worked with projects in various therapeutic areas including oncology, stroke, ophthalmology and orthopaedics.

Dr Cindy Lin Xinyi

Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

Dr. Xinyi (Cindy) Lin is an Assistant Professor at the Centre for Quantitative Medicine, Duke- NUS Medical School. She serves as the course coordinator for two modular courses in in the MCI programme: MCI5001 (Design and Planning of Clinical Studies) and MCI5006 (Design and Planning of Epidemiological Studies). Dr. Lin has extensive experience utilising advanced statistical methods in clinical research studies and genetic epidemiology investigations. She has taught biostatistics coursework to a diverse audience, including PhD students and clinical researchers.

Mihir Gandhi

Assistant Professor, Centre for Quantitative Medicine, Duke-NUS Medical School

Mihir Gandhi is an Assistant Professor in the Signature Program in Health Services & Systems Research, Lien Centre for Palliative Care, as well as the Head of Biostatistics Core team at the Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore. He is also affiliated with the Singapore Clinical Research Institute, Singapore as the Head of Biostatistics Department and the Global Health Group at the Center for Child Health Research, Tampere University, Finland as a Visiting Researcher.
He is primarily working on planning, analysis and reporting of clinical trials. He has experience in wide range of therapeutic areas such as oncology, paediatrics, and hypertension for drug and health services interventional trials. In addition to clinical trials, he has research interest in applied statistics, health-related quality of life, quality of healthcare and health state valuation.

A/Prof Edwin Chan

Associate Professor, Centre for Quantitative Medicine
Office of Clinical Sciences, Duke-NUS Medical School

A/Prof Chan is a clinical epidemiologist with over twenty years of experience in clinical research and evidence synthesis as the Chief Scientific Officer of the Singapore Clinical Research Institute (SCRI). He has been the Director of Cochrane Singapore since its establishment and is currently the Senior Scientific Advisor to SCRI. He teaches research literature critical appraisal skills and mentors students in clinical research (MCI programme, NUS). He has taught many research methodology courses on clinical trials, biostatistics, epidemiology, clinical practice guidelines (CPG) development, meta-analysis & evidence- based medicine (EBM). His interests are in the teaching of critical appraisal skills, epidemiology, health technology assessment and evidence synthesis.

Prof Cheung Yin Bun

Professor, Centre for Quantitative Medicine
Deputy Director, Centre for Quantitative Medicine, Duke-NUS Medical School

CHEUNG Yin Bun is Professor at Duke-NUS Medical School, Singapore, and Adjunct Professor at Tampere University, Finland. Prior to joining Duke-NUS, he was a Senior Lecturer at the London School of Hygiene & Tropical Medicine and Chief Scientific Officer at the Singapore Clinical Research Institute.
He received his degrees in social science, medical demography, statistics and paediatric epidemiology from institutions in Hong Kong, Singapore, and the United Kingdom. He has broad interest in the studies of global child health, statistical methodology, and quality of life in palliative care setting. He has been the principal investigator of multiple research grants on statistical methodology and quality of life research. He is the author of Statistical Analysis of Human Growth and Development (CRC Press, 2014) and co-author of Survival Analysis: A Practical Approach (Wiley, 2006). He is the developer of the Singapore Caregiver Quality of Life Scale.

Makoto Yawata,M.D., Ph.D.

Programme Director and Clinical-Scientist Mentor
Research Assistant Professor
Department of Pediatrics, NUS Yong Loo Lin School of Medicine Principal Investigator, Immunology Programme, Life Sciences Institute, National University of Singapore Principal Investigator, NUSMED Immunology Translational Research Programme, National University of Singapore

Makoto YAWATA is the Director of the MCI Programme, where he also serves as a clinician-scientist mentor guiding the students in designing and planning their clinical studies and as coordinator of the MCI wet lab experiential research workshop. He is affiliated with the Department of Paediatrics at the NUS Yong Loo Lin School of Medicine and a Principal Investigator in the Immunology Programme in the NUS Life Sciences Institute and the NUS Medicine Immunology Translational Research Programme. His clinical background is autoimmune diseases; however the research he conducted as postdoctoral fellow in the Department of Structural Biology in Stanford University School of Medicine has led him to become more involved in hematology and transplantation. His laboratory has been investigating the mechanisms of human natural killer cell responses against particular types of virus infections and cancer, and also in transplantation immunology.

Have Questions? Get in Touch with Us

    By submitting this form, you consent to the National University of Singapore (NUS) Yong Loo Lin School of Medicine collecting, using, and disclosing your business data, as provided in this form, for administrative and marketing purposes. For more information, please refer to our NUS Privacy Notice.